Intralesional Cemiplimab for Adult Patients with Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
R2810-ONC-1787
Phase 1 other active
Quick answer
Intralesional Cemiplimab for Adult Patients with Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma for Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma
- Phase
- Phase 1
- Modality
- other
- Status
- active